# The OCT SORT-OUT VIII Study

Study · id `cardio:ct-nct02253108` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02253108](<https://clinicaltrials.gov/study/NCT02253108>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02253108

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 160 participants.

## Technical summary

Registry record NCT02253108. Randomized; no masking; primary purpose treatment. Start 2014-05 (actual); primary completion 2015-04 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 160 participants (planned count; ClinicalTrials.gov record NCT02253108, source copy `cardio:ctgov-nct02253108-2026-01-02`, retrieved 2026-10-26)
- Started: 2014-05 (actual) (ClinicalTrials.gov record NCT02253108, source copy `cardio:ctgov-nct02253108-2026-01-02`, retrieved 2026-10-26)
- Primary completion: 2015-04 (actual) (ClinicalTrials.gov record NCT02253108, source copy `cardio:ctgov-nct02253108-2026-01-02`, retrieved 2026-10-26)
- Completion: 2026-06 (anticipated) (ClinicalTrials.gov record NCT02253108, source copy `cardio:ctgov-nct02253108-2026-01-02`, retrieved 2026-10-26)
- Countries: Denmark (ClinicalTrials.gov record NCT02253108, source copy `cardio:ctgov-nct02253108-2026-01-02`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02253108-2026-01-02`, retrieved 2026-10-26)

## The registry's words

- Brief title: The OCT SORT-OUT VIII Study
- Acronym: OCT SORT-OUT
- Condition: Coronary Artery Disease
- Condition: Angina Pectoris
- Condition: Myocardial Infarction
- Intervention (Device): Everolimus eluting bioresorbable polymer stent
- Intervention (Device): Biolimus eluting bioresorbable polymer stent
- Lead sponsor: Aarhus University Hospital Skejby
- Lead sponsor class: OTHER
- Collaborator: Biosensors International
- Collaborator class: OTHER
- Collaborator: Boston Scientific Corporation
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Angina pectoris (`cardio:angina-pectoris`)
- Registry condition terms include this condition: Coronary artery disease (`cardio:coronary-artery-disease`)
- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry lists this organization as the lead sponsor: Aarhus University Hospital Skejby (`cardio:org-aarhus-university-hospital-skejby`)
- Registry lists this organization as a collaborator: Biosensors International (`cardio:org-biosensors-international`)
- Registry lists this organization as a collaborator: Boston Scientific (`cardio:boston-scientific`)

## Provenance

Content hash: b7a53abc341799360fd52078236892ae8e87410e19e01443c4f89add1680b15f
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
